ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IHC Inspiration Healthcare Group Plc

13.75
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Inspiration Healthcare Group Plc LSE:IHC London Ordinary Share GB00BXDZL105 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.75 13.50 14.00 13.75 13.75 13.75 35,714 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Home Health Care Services 37.63M -6.03M -0.0673 -2.04 12.33M
Inspiration Healthcare Group Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker IHC. The last closing price for Inspiration Healthcare was 13.75p. Over the last year, Inspiration Healthcare shares have traded in a share price range of 13.25p to 54.00p.

Inspiration Healthcare currently has 89,660,000 shares in issue. The market capitalisation of Inspiration Healthcare is £12.33 million. Inspiration Healthcare has a price to earnings ratio (PE ratio) of -2.04.

Inspiration Healthcare Share Discussion Threads

Showing 976 to 1000 of 1000 messages
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
DateSubjectAuthorDiscuss
14/11/2024
17:30
Just 2804 shares were traded today and IHC business is worth 4.55% less than it was yesterday.

The nonsense that is AIM market and low liquidity / big spreads!

lammylover
14/11/2024
16:13
Not quite sure why resignation of COO should result in a share price decline as it looks like a clear out of old guard by CEO to my eyes.
gopher
08/10/2024
11:52
The decline in sales of t incubators is quite alarming and inventory now much too high. Having listened to presentation the emphasis seemed to be on better execution and appointment of CEO. They seemed confident they had stabilised matters but it looks a long road back to growth.
gopher
02/10/2024
08:07
VAST RECOURSES to re coupe some dosh ;)
g2theary
02/10/2024
06:50
Crikey poor shareholdersUtter bargepole this - 10p open?
scepticalinvestor
26/7/2024
11:10
gnnmartin

your SIPP account won't let you buy.

May I suggest that you (& everyone suffering from similar problems at their broker) move your account to a different broker (after first checking that the new broker would allow it).

The famously incompetent & useless British regulator is forcing brokers to do this type of interference with clients' execution accounts when an execution only account should by definition be left to the client to trade solely as he/she decides.

The UK, at times the stupidity beggars belief. Other examples are the Metropolitan police, the Post Office management (their illegal acts in intentionally prosecuting people they knew were innocent !!, ffs ! & the Govt ministers supervising that management), Grenfell tower (use of flammable building materials was allowed to happen).

smithie6
25/7/2024
06:34
$4.3m delayed contract finally signed - ventillators etc to be deliver in H2.
Good news.

lammylover
04/7/2024
06:22
Congratulations to management for awarding themselves nil cost options as a reward for decimating shareholder value.
eagle eye
03/7/2024
11:02
Worth catching up with ST article in IC. Lots of work on the sales side to do here but new management deserves a chance
gopher
26/6/2024
20:58
My SIPP won't let me subscribe. It's a "compliance" restriction, whatever that means. :-(
gnnmartin
26/6/2024
16:00
I notice that they don't seem to be doing investors presentation this time as previously regulars on investors meet.There seems no sales momentum and I would like to understand this aspect better before investing.
gopher
26/6/2024
12:05
Pretty grim, but at least signs of Roy Davies getting a grip and injecting some reality. Suspect mandate from major shareholders is to get it sorted and sold in 2 years. His track record in that regard is pretty good.

RD, new FD and team were always going to "kitchen sink" it this time. Cash and covenant breaches made a fund raise likely to access liquidity. Suspect new FD can get more cash out of working capital (e.g. inventory).

Positive focus on core products. Expensive vanity projects (Wave and cooling) have been shot with £4m capitalised R&D written off. Should now be much less capitalisation, which means earnings should better reflect cash generation.

US always going to be hard. The market favours manual rather than algorithmic controls (partly due to liability concerns).

Revenue bridge looks optimistic. More likely to be mid 30s again unless ME does actually land, but suspect more cost will come out.

Overall, pretty grim, but I will probably give RD and underlying tech the benefit of the doubt and subscribe.

mtioc
26/6/2024
08:55
It turns out buyers into recent rise didn't know more than me then. Fairly obvious these results were going to be poor otherwise CEO would have kept his job. Placing less predictable but I don't think the price is significant even NG priced like this recently, shareholders must take up rights to avoid dilution albeit minor.
gopher
26/6/2024
07:21
'Inspirational'? - I don't think so!
redwing1
26/6/2024
06:48
Concerning that they are also stating just £10m of revenue YTD leaving an absolute mountain to climb to hit £40m FY forecast. Sad to say but this company looks in serious distress if they have another big miss on the revenue line
nchanning
26/6/2024
06:21
Results in a nutshell:Everything down except for debtThe end.
scepticalinvestor
26/6/2024
06:20
Crikey, 14p placing. So 10p open? Condolences to s/h
scepticalinvestor
17/6/2024
09:59
I hope 60p is delivered, but fear any offer will be less.

Currently a break even business. Historically, c. £3m EBIT. Arguably, both of those flattered by consistent and repeated capitalisation of staff costs as R&D. Market cap at 28p is £19m with debt of £8m giving an EV of £27m. 60p implies an EV of £46m or 15x+ best EBIT. 30-40p more likely. Purchaser appears to have acquisition rationale/intent, so has probably spoken to major shareholders.

Top 4 institutions and founders account for 54%. Suspect founders who no longer work in business (including former CEO) would like cash. May be lower than hoped for, but cash today always has appeal.

Don't think any of current Board have any interest in "hanging on".

Let's see.

mtioc
17/6/2024
09:46
No they aren't.
If anything, it's the other way round : 'funds' (as you call them) transferring out of the under -performer APH into IHC.
Suggest you do the same BH.

dogwalker
17/6/2024
08:30
Some funds transferring to APH
blackhorse23
14/6/2024
13:32
They have undoubtedly struggled following the acquisition then integration of SLE Top, the overdue changes at the top should rectify that. I would have thought an offer in excess of 60p would be required to stand any chance of success.
nafafa
14/6/2024
11:23
Yes. Not today but someone wants the company imo
babbler
14/6/2024
11:01
Hi Jaknife - possible stake building going on by Mennen Medical, see 13/6 RNS.
strollingmolby
14/6/2024
10:49
I cant find an RNS. I have I missed other news?
jaknife
14/6/2024
10:38
Guess you missed out on quite a rise now. What do these buyers know that you don't?
babbler
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older

Your Recent History

Delayed Upgrade Clock